Enzoimmune Active Oral Spray

LIQUID FOOD SUPPLEMENT in the form of a spray. The active substance of the food supplement has been registered for use in the USA with FDA (NDI reg. № 1083). Enzoimunne Active is a registered trade mark of Rosetta Lifecare Bulgaria LTD and is produced under license in Bulgaria (EU) under reg. № 5293/903. This bio-product has shown low toxicity and is well accepted by the body system. Clinical trials show improvements in immunity.

THE ACTIVE SUBSTANCE is Inactivated pepsin fragment (IPF) derived from pepsin from mucosa (CAS № 9001-75-6) and the method of its extraction and application is patented in the USA as follows: US Patent № 8,309,072 – Irreversible inactivated pepsinogen fragment for modulating immune function. IPF is a complex platform that could be used alone or as a concomitant therapy for a variety of diseases. The substance is made from standardized, purified and lyophilized pepsin containing a polypeptide chain of 327 amino acid residues and one phosphoric acid residue. Using a patented method, a peptide chain of 36 amino acids – (IPF) is isolated, which is involved in a series of immune responses.

Directions:
For application of EnzoImmune Active Spray – liquid dietary supplement.
Registration number: EU – BG reg. # 902.
Trade name: EnzoImmune Active Spray
Active substance: inactivated pepsin fragment (IPF), US patent # 8,309,072; USA – FDA reg.# 1083 – 4,5mg / ml.
Additional ingredients: sodium citrate, potassium corobate, sodium benzoate, distilled water.
Recommended daily dose: – 3ml – 3 x 8-9 sprays (under the tongue).
Description: Transparent, colorless or slightly yellowish liquid.
Dietary supplement form: 50ml oral spray (under the tongue).
Properties: It has a beneficial effect on the immune system, enhancing its ability to fight infections, promoting antibody production and promoting the body’s antioxidant defenses. Helps support liver function and keep cholesterol within normal limits.
Method of application and recommended dosage: Adults and children over 14 years of age, to modulate the immune system. The initial stage of absorption begins in the oral cavity after use. The method of administration of the substance is orally, 3 ml per day (3 x 8-9 sprays under the tongue) for three consecutive days per week for 5 weeks. A break of 1 week is recommended, after which the course is repeated 2 more times. Intake of food or liquids for 30 minutes after use is not recommended.
Contraindications: Not established, but hypersensitivity and allergic reactions may occur.
Usage in pregnancy and lactation: Consult with your doctor.
Side effects: Not established. Individual intolerance is possible. Does not affect the driving and use of machines.
Special instructions: Do not exceed the recommended daily dose. Do not use as a substitute for a varied diet.
Interactions with other medicines: No drug interactions have been reported. As it aids the immune system, EnzoImmune Active can be combined with anti-inflammatory agents, chemotherapies, antiviral, antibacterial and antimycotic therapies and more. Do not use together with immunosuppressants.
Expiration: 24 months from production date.
Storage: Store in dark and cool place at room temperature. Keep away from children.
Manufactured: in EU,
for Roseta Lifecare Bulgaria LTD, 8b Bialo Pole Str., 1618 Sofia, Bulgaria,
tel: + 359 89 444 03 60, email: rosettabg@abv.bg

www.rosettalifecarebg.org
www.enzoimmune.com